Abstract
Osteoarthritis (OA) is a common, chronic and painful condition. It is the most common of all rheumatic disorders and is destined to become one of the most prevalent and costly diseases in our society. The conventional therapeutic options employed in the management of OA are simple analgesics and NSAIDs, but these options frequently produce sub-optimal benefit and are associated with an adverse-safety profile. Unsurprisingly patients are looking to alternative and complementary medicine.
The aim of this article was to review the available literature on the effectiveness and safety of ‘natural remedies’ for the treatment of OA. Computerised literature searches were carried out for systematic reviews and randomised controlled trials examining the role of ‘natural remedies’ in the treatment of OA.
There have been few randomised controlled trials of ‘natural remedies’ that have satisfied the internationally agreed standards. There was, however, evidence of efficacy for glucosamine, chondroitin sulfate and possibly avocado/soybean unsaponifiables for the symptomatic relief of OA. To date, it is not established whether any of the ‘natural remedies’ are capable of chondroprotection.
Even if ‘natural remedies’ are only modestly effective, they are widely available and well tolerated, suggesting that they may play a significant role in the management of OA in the elderly.
Similar content being viewed by others
Notes
Use of tradenames is for product identification only and does not imply endorsement.
References
Lawrence R, Hochberg MC, Kelsey JL, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989; 16: 427–41
Hochberg MC. Epidemiologic considerations in the primary prevention of osteoarthritis. J Rheumatol 1991; 18: 1438–40
Murray CJL, Lopez A. The global burden of disease. Geneva: World Health Organization, 1997
Eccles M, Freemantle N, Mason J, for the North of England Non-Steroidal Anti-Inflammatory Drug Guidelines Development Group. North of England evidence based guidelines development project: summary guidelines for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. BMJ 1998; 317: 526–30
Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569–75
Rao JK, Mihaliak K, Kroenke K, et al. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999; 131: 409–16
Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998; 279: 1548–53
Bellamy N, Buchanan WW. Outcome measurement in osteoarthritis clinical trials: the case for standardization. Clin Rheumatol 1984; 3: 293–305
Lequesne M, Brandt K, Bellamy N, et al. Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol Suppl 1994; 41: 65–71
Bellamy N, Kirwan J, Boers M, et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis: consensus development at OMERACT III. J Rheumatol 1996; 24(4): 799–802
Walker-Bone K, Javaid MK, Arden N, et al. Medical management of osteoarthritis. BMJ 2000; 321: 936–40
Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000; 59: 936–44
Chard J, Dieppe P. The case for nonpharmacologic therapy of osteoarthritis. Curr Rheumatol Rep 2001; 3: 251–7
Moore RA, Tramer MR, Carroll D, et al. Topical non-steroidal anti-inflammatory drugs are effective and safe for osteoarthritis. BMJ 1998; 316: 333–8
Fusco BM, Giacovazzo M. Peppers and pain — the promise of capsaicin. Drugs 1997; 53: 909–14
Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 1991; 13: 383–95
McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 1992; 19: 604–7
Schinitzer TJ, Morton C, Coker S, et al. The effectiveness of reduced applications of topical capsaicin (0.025%) in osteoarthritis [abstract]. Arthritis Rheum 1992; 35: S132
Altman RD, Aven A, Holmburg CE, et al. Capsaicin cream 0.025% as monotherapy for osteoarthritis: a double blind study. Semin Arthritis Rheum 1994; Suppl. 23: 25–33
McCleane G. The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: a randomized, double blind, placebo controlled study. Eur J Pain 2000; 4: 355–60
Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. Eur J Clin Pharmacol 1994; 46: 517–22
Randall C, Randall H, Dobbs F, et al. Randomised controlled trial of nettle sting for treatment of base-of-thumb pain. J R Soc Med 2000; 93: 305–9
Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology 2001; 40: 779–93
Kulkarni R, Patki P, Jog V, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991; 33: 91–5
Lanhers M, Fleurentin J, Mortier F, et al. Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med 1992; 58: 117–23
Baghdikian B, Lanhers M, Fleurentin J, et al. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri. Planta Med 1997; 63(2): 171–6
Bhattacharya A, Bhattachraya S. Anti-oxidant activity of Harpagophytum procumbens (Devil’s Claw). Br J Phytotherapy 2002; 5: 68–71
Guyader M. Les plantes antirhumatismales. Etude historique et pharmacologique, et etude clinique du nebulisat d’Hargophytum procumbens DC chez 50 patients arthrosiques suivis en service hospitalier [PhD thesis]. Paris: Universite Pierre et Marie Curie, 1984
Lecomte A, Costa JP. Hapagophytum dans l’arthrose: Etudes en double insu contre placebo. Le Magazine 1992; 15: 27–30
Piscoya J, Rodriguez Z, Bustamunte S, et al. Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee:mechanisms of action of the species Uncaria guianensis. Inflamm Res 2001; 50: 442–8
Bliddal H, Resetzsky A, Schlichting P, et al. A randomised, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 2000; 8: 9–12
Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001; 44: 2461–2
Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. CD002947. Oxford: Update Software, 2001
Ryttig K, Schlamowitz P, Warnoe O, et al. Gitadyl versus ibuprofen in patients with osteoarthrosis: the result of a double-blind, randomized cross-over study. Ugeskr Laeger 1991; 153: 2298–9
Ernst E. The efficacy of phytodolor for the treatment of musculoskeletal pain: a systematic review of randomized clinical trials. Natural Medicine Online 2000; 3(2)
Hawel R. Phytodolor vs Diclofenac bei rheumatischen Erkrankungen. Interner Forschungsbericht. Darmstadt: Steigerwald GmbH, 1991
Huber V. Therapie degenerativer rheumatischer Erkrankungen. Fortschr Med 1991; 109: 248–50
Schadler W. Phytolodor N zur Behandlung aktivierter Arthrosen. Rheumatologika 1988; 8: 280–90
Baumann D, Focke G, Kornosoff G. Phytodolor bei patienten mit aktivierter Gonarthrose, Koxarthrose bzw. Schulter-Arm-Syndrom. multizentrische randomisierte Doppelblindstudie versus Diclofenac-Natrium. Interner Forschungsbericht. Darmstadt: Steigerwald GmbH, 1989
Mills SY, Jacoby RK, Chacksfield M, et al. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: a double-blind study. Br J Rheumatol 1996; 35: 874–8
Schmid B, Ludtke R, Selbmann H, et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double-blind clinical trial. Phytother Res 2001; 15: 344–50
Ferraz M, Pereira R, Iwata N, et al. A popular analgesic tea: a double-blind cross-over trial in osteoarthritis. Clin Exp Rheumatol 1991; 9: 205–6
Boumediene K, Felisaz N, Bogdanowicz P, et al. Avocado/soya unsaponifiables enhance the expression of transforming growth factor beta1 and beta2 in clutured articular chondrocytes. Arthritis Rheum 1999; 42: 148–56
Henrotin Y, Labasse A, Jaspar J, et al. Effects of three avocado/ soybean unsaponifiable mixtures on metalloproteinases, cytokines, and prostaglandin E2 production by human articular chondrocytes. Clin Rheumatol 1998; 17: 31–9
Appelboom T, Schuermans J, Verbruggen G, et al. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. Scand J Rheumatol 2001; 30: 242–7
Blotman F, Maheu E, Wulwik A, et al. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. Rev Rhum Mal Osteoartic 1997; 41: 825–34
Maheu E, Mazieres B, Valat J, et al. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, doubleblind, placebo-controlled, multicenter clinical trial with six months treatment and a two-month follow-up demonstrating a persistent effect. Arthritis Rheum 1998; 41: 81–91
Lequesne M, Maheu E, Cadet C, et al. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum 2002; 47: 50–8
Theodosakis J, Adderly B, Fox B. The arthritis cure. New York: St Martin’s Press, 1997
McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis. JAMA 2000; 283: 1469–75
Adams ME. Hype about glucosamine. Lancet 1999; 354: 353–4
Hughes R. Oral glucosamine sulphate in the treatment of osteoarthritis: a review of the literature. Ann Rheum Dis 1999; 8(EULAR Suppl.): 124
Delafuente JC. Glucosamine in the treatment of osteoarthritis. Rheum Dis Clin North Am 2000; 26: 1–11
Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. CD002946. Oxford: Update Software, 2001
Chard J, Dieppe P. Glucosamine for osteoarthritis: magic, hype or confusion? BMJ 2001; 322: 1439
Hughes RA, Carr AJ. A randomised, double-blind, placebo-controlled trial of glucosamine to control pain in osteoarthritis of the knee [abstract]. Arthritis Rheum 2000; 45: S384
Reginster J, Deroisy R, Rovati LC, et al. Glucosamine sulfate significantly reduces progession of knee osteoarthritis over 3 years: a large, randomised, placebo-controlled prospective trial. Lancet 2001; 357: 251–6
Brief AA, Maurer SG, Di Cesare PE. Use of glucosamine and chondroitin sulfate in the management of osteoarthritis. J Am Acad Orthop Surg 2001; 9: 352–3
Hauselmann HJ. Nutripharmaceuticals for osteoarthritis. Best Pract Res Clin Rheumatol 2001; 15: 595–607
Creamer P, Lethbridge-Cejku M, Hochberg MC. Factors associated with functional impairment in symptomatic knee osteoarthritis. Rheumatology 2000; 39: 490–6
Kelly GS. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Alternative Med Rev 1998; 3: 27–39
Walker-Bone K, Javaid MK, Arden N, et al. Glucosamine and chondroitin may help in osteoarthritis [letter]. BMJ 2001; 322: 673
Leeb BF, Schweitzer H, Montag K, et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2001; 27: 205–11
Leeb BF. Management of knee osteoarthritis. Ann Rheum Dis 2001; 60: 984
Acknowledgements
No sources of funding were used to assist in the preparation of this manuscript. The author has no conflicts of interest that are directly relevant to the content of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walker-Bone, K. ‘Natural Remedies’ in the Treatment of Osteoarthritis. Drugs Aging 20, 517–526 (2003). https://doi.org/10.2165/00002512-200320070-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200320070-00004